Cart
sales@molnova.com
Bendamustine
CAS No. 16506-27-7
Bendamustine( SDX105 )
Catalog No. M21612 CAS No. 16506-27-7
Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 82 | In Stock |
|
| 2MG | 43 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 258 | In Stock |
|
| 50MG | 398 | In Stock |
|
| 100MG | 594 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1274 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBendamustine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
-
DescriptionBendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
-
In Vitro——
-
In Vivo——
-
SynonymsSDX105
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Areacancer
-
IndicationHodgkin's Disease Lymphoma
Chemical Information
-
CAS Number16506-27-7
-
Formula Weight358.26
-
Molecular FormulaC16H21Cl2N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:72 mg/mL (200.97 mM)
-
SMILESCn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Patekar M B Milunovi V Jakobac K M et al. Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia[J]. Acta Clinica Croatica 2018 57(3):542-553.
molnova catalog
related products
-
2-(5-methyl-1H-imida...
2-(5-methyl-1H-imidazol-4-yl)ethan-1-amine hydrochloride is a compound used as a molecular building block.
-
DZ2002
DZ2002, an orally active, reversible, and low-cytotoxic type III SAHH inhibitor (Ki=17.9 nM), exhibits significant immunosuppressive activity.
-
5,7-Dihydroxyisoflav...
5,7-Dihydroxyisoflavone
